CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc.

1:19-cv-02120

Overview

Case Number 1:19-cv-02120
Filing Date 2019-11-12
Status Terminated
Termination Date 2022-05-04
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Alexion Pharmaceuticals, Inc. Operating Company

Represented By

1 Attorneys Listed

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Plaintiff

Chugai Pharmaceutical Co., Ltd. Operating Company

Represented By

3 Attorneys Listed

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

David M. Fry

JPMorgan Chase & Co.

Tel: +1 (302) 455-3374

JPMorgan Chase & Co., 4041 Ogletown Stanton Road

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10472623
Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
Filed: 2018-04-13
Issued: 2019-11-12
Active (11.4 yrs remaining)
Expires: 2038-04-13

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Alexion Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2776153.) - filed by Chugai Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(myr) (Entered: 11/12/2019)

Entry #1 • 2019-11-12
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) (Entered: 11/12/2019)

Entry #2 • 2019-11-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,472,623. (myr) (Entered: 11/12/2019)

Entry #3 • 2019-11-12
1

Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Roche Holding Ltd. for Chugai Pharmaceutical Co., Ltd. filed by Chugai Pharmaceutical Co., Ltd. (myr) (Entered: 11/12/2019)

Entry #4 • 2019-11-12
1
Pleading / Complaint

SUMMONS Returned Executed by Chugai Pharmaceutical Co., Ltd.. Alexion Pharmaceuticals, Inc. served on 11/12/2019, answer due 12/3/2019. (Hoeschen, Nathan) (Entered: 11/12/2019)

Entry #5 • 2019-11-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc